In order to deliver protection against viral pathogens and allow at the same time necessary steroid therapy, scientists generated glucocorticoid-resistant T cells by CRISPR/Cas9-mediated knockout of the glucocorticoid receptor in primary human virus-specific T-cell products.
[Molecular Therapy]
6445212
{6445212:Y4JXJERA}
apa
50
1
150767
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/